ArticleMediterranean journal of hematology and infectious diseases2023

Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results.

Mehmet Hilmi Dogu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.